Convex CRO provides research solutions designed to support biotech and generic companies to the development of their research products: - FIM
- Phase 1 - healthy volunteers and patient population
- PK, PD, BE/ BA clinical studies Early Phase CRO and Clinical Phase I Pharmacology Unit combine a variety of expertise into the development of Phase I trials, Bioequivalence and bioavailability study and wide gamma of pharmacokinetic and pharmacodynamic studies. We operate in Eastern Europe, Sofia, Bulgaria. In addition to having a great team of experts, we have at our disposal a state-of-the-art 15-bed pharmacology research unit which can meet any early phase clinical study protocol requirements for: single center study, bioequivalence study, bioavailability study, phase I study, vaccine study, food supplement study and medical device study. Convex is a full services CRO supporting pharmaceutical industry in the conduct of a variety of research programmes by covering A-Z services for their study related requirements. We support research and development companies in Study start-up, Medical writing (protocol/ICF/subject specific clinical subject documentation/ final study report development), Clinical trial regulatory services (consultation and submission to RA/CEC/EC), IMP labeling and packaging, Investigator meeting organization, Contracting, Healthy subject/patient recruitment, Clinical trial operations services, Clinical monitoring, Safety reporting, Project Management, PK analysis of blood samples, Data Management and Biostatistics (electronic or paper-based CRF), eCTD formatting of study documentation. We are a full service vendor dedicated to the conduct of variety of single center clinical trials.
